Wirkstoffentwicklung in den letzten Jahren Antipsychotica, Teil 1

Pharmazie in Unserer Zeit

Volumn 25, Issue 1, 1996, Pages 28-38

  Eiden, Fritz ^a   Lentzen, Hans ^b  

^a Anschrife Inst f Pharmazie/LU

^b Madaus AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; DOPAMINE RECEPTOR; NEW DRUG; SEROTONIN RECEPTOR; UNINDEXED DRUG;

ANIMAL; CHEMISTRY; HUMAN; REVIEW; DRUG DEVELOPMENT; DRUG MECHANISM; DRUG STRUCTURE; DYSKINESIA; EXTRAPYRAMIDAL SYMPTOM; PSYCHOSIS; SEDATION; SHORT SURVEY; SIDE EFFECT;

ANIMALS; ANTIPSYCHOTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HUMANS; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0029682822     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.19960250108     Document Type: Article

References (82)

1. Nuhn, P., Wiese, M., Pharm. Ztg. 140 (1995), 1830-1831. Nach einer anderen Erklärung wollte man mit Medicinal Chemistry eigentlich eine Medical Chemistry bezeichnen, womit Medizinische und Pharmazeutische Chemie auch Synonyme sein könnten.
2. Reis-Arndt, E., Pharm. Ind. 55 (1993), 14-21.
3. Ganellin, C. R., Roberts, S. M. (Edit.), Medicinal Chemistry, The Role of Organic Chemistry in Drug Research, Sec. Ed., Academic Press London 1993; Testa, B., Kyburz, E., Fuhrer, W., Giger, R. (Edit.), Perspectives in Medicinal Chemistry, VHCA Basel und VCH Weinheim 1993; Silverman, R. B., Medizinische Chemie (Herausg. J. K. Seydel), VCH Weinheim 1995; Krogsgaard-Larsen, P., Bundgaard, H. (Edit.), A Textbook of Drug-Design and Development, Harwood Academic Publishers Chur 1991. H. Kubinyi, Pharm. unserer Zeit 23 (1994), 158-166 und 281-290.
4. Ganellin, C. R., Roberts, S. M. (Edit.), Medicinal Chemistry, The Role of Organic Chemistry in Drug Research, Sec. Ed., Academic Press London 1993; Testa, B., Kyburz, E., Fuhrer, W., Giger, R. (Edit.), Perspectives in Medicinal Chemistry, VHCA Basel und VCH Weinheim 1993; Silverman, R. B., Medizinische Chemie (Herausg. J. K. Seydel), VCH Weinheim 1995; Krogsgaard-Larsen, P., Bundgaard, H. (Edit.), A Textbook of Drug-Design and Development, Harwood Academic Publishers Chur 1991. H. Kubinyi, Pharm. unserer Zeit 23 (1994), 158-166 und 281-290.
5. Ganellin, C. R., Roberts, S. M. (Edit.), Medicinal Chemistry, The Role of Organic Chemistry in Drug Research, Sec. Ed., Academic Press London 1993; Testa, B., Kyburz, E., Fuhrer, W., Giger, R. (Edit.), Perspectives in Medicinal Chemistry, VHCA Basel und VCH Weinheim 1993; Silverman, R. B., Medizinische Chemie (Herausg. J. K. Seydel), VCH Weinheim 1995; Krogsgaard-Larsen, P., Bundgaard, H. (Edit.), A Textbook of Drug-Design and Development, Harwood Academic Publishers Chur 1991. H. Kubinyi, Pharm. unserer Zeit 23 (1994), 158-166 und 281-290.
6. Ganellin, C. R., Roberts, S. M. (Edit.), Medicinal Chemistry, The Role of Organic Chemistry in Drug Research, Sec. Ed., Academic Press London 1993; Testa, B., Kyburz, E., Fuhrer, W., Giger, R. (Edit.), Perspectives in Medicinal Chemistry, VHCA Basel und VCH Weinheim 1993; Silverman, R. B., Medizinische Chemie (Herausg. J. K. Seydel), VCH Weinheim 1995; Krogsgaard-Larsen, P., Bundgaard, H. (Edit.), A Textbook of Drug-Design and Development, Harwood Academic Publishers Chur 1991. H. Kubinyi, Pharm. unserer Zeit 23 (1994), 158-166 und 281-290.
7. Ganellin, C. R., Roberts, S. M. (Edit.), Medicinal Chemistry, The Role of Organic Chemistry in Drug Research, Sec. Ed., Academic Press London 1993; Testa, B., Kyburz, E., Fuhrer, W., Giger, R. (Edit.), Perspectives in Medicinal Chemistry, VHCA Basel und VCH Weinheim 1993; Silverman, R. B., Medizinische Chemie (Herausg. J. K. Seydel), VCH Weinheim 1995; Krogsgaard-Larsen, P., Bundgaard, H. (Edit.), A Textbook of Drug-Design and Development, Harwood Academic Publishers Chur 1991. H. Kubinyi, Pharm. unserer Zeit 23 (1994), 158-166 und 281-290.
8. Weber, L., Nachr. Chem. Tech. Lab. 42 (1994), 698-701 und Kutscher, B., ibid. 43 (1995), 168-169.
9. Weber, L., Nachr. Chem. Tech. Lab. 42 (1994), 698-701 und Kutscher, B., ibid. 43 (1995), 168-169.
10. Mutschler, E., Arzneimittelwirkungen 6. Aufl., Wissenschaftliche Verlagsgesellschaft Stuttgart 1991, 125-132; Coper, H., Helmchen, H. in Forth, W., Henschler, D., Rummel, W., Starke, K., Pharmakologie und Toxikologie, Wissenschaftsverlag Mannheim 1992, S. 282-287; Baldessarini, R. J., in Good-man and Gilman's The Pharmacological Basis of Therapeutics, Pergamon Press New York 1990, S. 386-404.
11. Mutschler, E., Arzneimittelwirkungen 6. Aufl., Wissenschaftliche Verlagsgesellschaft Stuttgart 1991, 125-132; Coper, H., Helmchen, H. in Forth, W., Henschler, D., Rummel, W., Starke, K., Pharmakologie und Toxikologie, Wissenschaftsverlag Mannheim 1992, S. 282-287; Baldessarini, R. J., in Good-man and Gilman's The Pharmacological Basis of Therapeutics, Pergamon Press New York 1990, S. 386-404.
12. Mutschler, E., Arzneimittelwirkungen 6. Aufl., Wissenschaftliche Verlagsgesellschaft Stuttgart 1991, 125-132; Coper, H., Helmchen, H. in Forth, W., Henschler, D., Rummel, W., Starke, K., Pharmakologie und Toxikologie, Wissenschaftsverlag Mannheim 1992, S. 282-287; Baldessarini, R. J., in Good-man and Gilman's The Pharmacological Basis of Therapeutics, Pergamon Press New York 1990, S. 386-404.
13. Sibly, R., Monsma, Jr., F. J., Trends Pharmacol. Sci. 13 (1992), 61-69; Seeman, Ph., van Tool, H. H. M., ibid. 15, (1994), 264-270; Andreasen, N. C., Curr. Opinion Neurobiol. 4 (1994) 245-251.
14. Sibly, R., Monsma, Jr., F. J., Trends Pharmacol. Sci. 13 (1992), 61-69; Seeman, Ph., van Tool, H. H. M., ibid. 15, (1994), 264-270; Andreasen, N. C., Curr. Opinion Neurobiol. 4 (1994) 245-251.
15. Sibly, R., Monsma, Jr., F. J., Trends Pharmacol. Sci. 13 (1992), 61-69; Seeman, Ph., van Tool, H. H. M., ibid. 15, (1994), 264-270; Andreasen, N. C., Curr. Opinion Neurobiol. 4 (1994) 245-251.
16. Kebabian, J., W., Neumeyer, J. L., The RBI-Handbook of Receptor Classification, Research Biochemicals International, Natick 1994, 58-61.
17. Watson, St., Girdlestone, D., Trends Pharmacol. Sci. 15, (1994) Suppl., Receptor & Ion Channel Nomenklatura, 25-27.
18. Reynolds, G. P., Trends Pharmacol. Sci. 13 (1992), 116-121; Müller, W. E., Dtsch. Apoth. Ztg. 132 (1992), 173-180; Lieberman, J. A., Brit. J. Psychiatry 163 (1993), Suppl. 22, 7-18; Laux, G., Dtsch. Apoth. Ztg. 132 (1992), 241-245; Tricklebank, M. D., Bristow, L. J., Hutson, P. H. in Jucker, E., Progress in Drug Research 38, (1992), 299-333; Kozikowski, A. P. (Edit.), Drug Design for Neuroscience, Ravenpress New York 1993; Wise, D., Heffner, Th. G. in Bristol, J. A., Annu. Rep. Med. Chem. 26 (1991), 53-62 sowie 27 (1992), 49-57 und Howard, H. R., Seeger, Th. F., ibid. 28 (1993), 39-47.
19. Reynolds, G. P., Trends Pharmacol. Sci. 13 (1992), 116-121; Müller, W. E., Dtsch. Apoth. Ztg. 132 (1992), 173-180; Lieberman, J. A., Brit. J. Psychiatry 163 (1993), Suppl. 22, 7-18; Laux, G., Dtsch. Apoth. Ztg. 132 (1992), 241-245; Tricklebank, M. D., Bristow, L. J., Hutson, P. H. in Jucker, E., Progress in Drug Research 38, (1992), 299-333; Kozikowski, A. P. (Edit.), Drug Design for Neuroscience, Ravenpress New York 1993; Wise, D., Heffner, Th. G. in Bristol, J. A., Annu. Rep. Med. Chem. 26 (1991), 53-62 sowie 27 (1992), 49-57 und Howard, H. R., Seeger, Th. F., ibid. 28 (1993), 39-47.
20. Reynolds, G. P., Trends Pharmacol. Sci. 13 (1992), 116-121; Müller, W. E., Dtsch. Apoth. Ztg. 132 (1992), 173-180; Lieberman, J. A., Brit. J. Psychiatry 163 (1993), Suppl. 22, 7-18; Laux, G., Dtsch. Apoth. Ztg. 132 (1992), 241-245; Tricklebank, M. D., Bristow, L. J., Hutson, P. H. in Jucker, E., Progress in Drug Research 38, (1992), 299-333; Kozikowski, A. P. (Edit.), Drug Design for Neuroscience, Ravenpress New York 1993; Wise, D., Heffner, Th. G. in Bristol, J. A., Annu. Rep. Med. Chem. 26 (1991), 53-62 sowie 27 (1992), 49-57 und Howard, H. R., Seeger, Th. F., ibid. 28 (1993), 39-47.
21. Reynolds, G. P., Trends Pharmacol. Sci. 13 (1992), 116-121; Müller, W. E., Dtsch. Apoth. Ztg. 132 (1992), 173-180; Lieberman, J. A., Brit. J. Psychiatry 163 (1993), Suppl. 22, 7-18; Laux, G., Dtsch. Apoth. Ztg. 132 (1992), 241-245; Tricklebank, M. D., Bristow, L. J., Hutson, P. H. in Jucker, E., Progress in Drug Research 38, (1992), 299-333; Kozikowski, A. P. (Edit.), Drug Design for Neuroscience, Ravenpress New York 1993; Wise, D., Heffner, Th. G. in Bristol, J. A., Annu. Rep. Med. Chem. 26 (1991), 53-62 sowie 27 (1992), 49-57 und Howard, H. R., Seeger, Th. F., ibid. 28 (1993), 39-47.
22. Reynolds, G. P., Trends Pharmacol. Sci. 13 (1992), 116-121; Müller, W. E., Dtsch. Apoth. Ztg. 132 (1992), 173-180; Lieberman, J. A., Brit. J. Psychiatry 163 (1993), Suppl. 22, 7-18; Laux, G., Dtsch. Apoth. Ztg. 132 (1992), 241-245; Tricklebank, M. D., Bristow, L. J., Hutson, P. H. in Jucker, E., Progress in Drug Research 38, (1992), 299-333; Kozikowski, A. P. (Edit.), Drug Design for Neuroscience, Ravenpress New York 1993; Wise, D., Heffner, Th. G. in Bristol, J. A., Annu. Rep. Med. Chem. 26 (1991), 53-62 sowie 27 (1992), 49-57 und Howard, H. R., Seeger, Th. F., ibid. 28 (1993), 39-47.
23. Reynolds, G. P., Trends Pharmacol. Sci. 13 (1992), 116-121; Müller, W. E., Dtsch. Apoth. Ztg. 132 (1992), 173-180; Lieberman, J. A., Brit. J. Psychiatry 163 (1993), Suppl. 22, 7-18; Laux, G., Dtsch. Apoth. Ztg. 132 (1992), 241-245; Tricklebank, M. D., Bristow, L. J., Hutson, P. H. in Jucker, E., Progress in Drug Research 38, (1992), 299-333; Kozikowski, A. P. (Edit.), Drug Design for Neuroscience, Ravenpress New York 1993; Wise, D., Heffner, Th. G. in Bristol, J. A., Annu. Rep. Med. Chem. 26 (1991), 53-62 sowie 27 (1992), 49-57 und Howard, H. R., Seeger, Th. F., ibid. 28 (1993), 39-47.
24. Reynolds, G. P., Trends Pharmacol. Sci. 13 (1992), 116-121; Müller, W. E., Dtsch. Apoth. Ztg. 132 (1992), 173-180; Lieberman, J. A., Brit. J. Psychiatry 163 (1993), Suppl. 22, 7-18; Laux, G., Dtsch. Apoth. Ztg. 132 (1992), 241-245; Tricklebank, M. D., Bristow, L. J., Hutson, P. H. in Jucker, E., Progress in Drug Research 38, (1992), 299-333; Kozikowski, A. P. (Edit.), Drug Design for Neuroscience, Ravenpress New York 1993; Wise, D., Heffner, Th. G. in Bristol, J. A., Annu. Rep. Med. Chem. 26 (1991), 53-62 sowie 27 (1992), 49-57 und Howard, H. R., Seeger, Th. F., ibid. 28 (1993), 39-47.
25. Reynolds, G. P., Trends Pharmacol. Sci. 13 (1992), 116-121; Müller, W. E., Dtsch. Apoth. Ztg. 132 (1992), 173-180; Lieberman, J. A., Brit. J. Psychiatry 163 (1993), Suppl. 22, 7-18; Laux, G., Dtsch. Apoth. Ztg. 132 (1992), 241-245; Tricklebank, M. D., Bristow, L. J., Hutson, P. H. in Jucker, E., Progress in Drug Research 38, (1992), 299-333; Kozikowski, A. P. (Edit.), Drug Design for Neuroscience, Ravenpress New York 1993; Wise, D., Heffner, Th. G. in Bristol, J. A., Annu. Rep. Med. Chem. 26 (1991), 53-62 sowie 27 (1992), 49-57 und Howard, H. R., Seeger, Th. F., ibid. 28 (1993), 39-47.
26. Reynolds, G. P., Trends Pharmacol. Sci. 13 (1992), 116-121; Müller, W. E., Dtsch. Apoth. Ztg. 132 (1992), 173-180; Lieberman, J. A., Brit. J. Psychiatry 163 (1993), Suppl. 22, 7-18; Laux, G., Dtsch. Apoth. Ztg. 132 (1992), 241-245; Tricklebank, M. D., Bristow, L. J., Hutson, P. H. in Jucker, E., Progress in Drug Research 38, (1992), 299-333; Kozikowski, A. P. (Edit.), Drug Design for Neuroscience, Ravenpress New York 1993; Wise, D., Heffner, Th. G. in Bristol, J. A., Annu. Rep. Med. Chem. 26 (1991), 53-62 sowie 27 (1992), 49-57 und Howard, H. R., Seeger, Th. F., ibid. 28 (1993), 39-47.
27. Barnett, A., Drugs. Fut. 11 (1986), 49-56; Andersen, P. H., Nielsen, E. B., Drug News Perspect. 4 (1991), 150-157; Petterson, I., Liljefors, T., Bogeso, K., J. Med. Chem. 33 (1990), 2197-2204; Weinstock, J., Hieble, J. P., Wilson, J. W., Drugs Fut. 10 (1995), 645-697.
28. Barnett, A., Drugs. Fut. 11 (1986), 49-56; Andersen, P. H., Nielsen, E. B., Drug News Perspect. 4 (1991), 150-157; Petterson, I., Liljefors, T., Bogeso, K., J. Med. Chem. 33 (1990), 2197-2204; Weinstock, J., Hieble, J. P., Wilson, J. W., Drugs Fut. 10 (1995), 645-697.
29. Barnett, A., Drugs. Fut. 11 (1986), 49-56; Andersen, P. H., Nielsen, E. B., Drug News Perspect. 4 (1991), 150-157; Petterson, I., Liljefors, T., Bogeso, K., J. Med. Chem. 33 (1990), 2197-2204; Weinstock, J., Hieble, J. P., Wilson, J. W., Drugs Fut. 10 (1995), 645-697.
30. Barnett, A., Drugs. Fut. 11 (1986), 49-56; Andersen, P. H., Nielsen, E. B., Drug News Perspect. 4 (1991), 150-157; Petterson, I., Liljefors, T., Bogeso, K., J. Med. Chem. 33 (1990), 2197-2204; Weinstock, J., Hieble, J. P., Wilson, J. W., Drugs Fut. 10 (1995), 645-697.
31. Berger, G. u. a., J. Med. Chem., 32 (1989), 1913-1921.
32. Drugs Fut. 13 (1988), 988-989.
33. Wyrick, S. D., u.a., J. Med. Chem. 37 (1994), 4317-4328.
34. Seiler, M. P. u. a. in Testa, B., Fuhrer, W., Kyburz, E., Giger, R., Perspectives in Medicinal Chemistry, VCH, Basel und VCH, Weinheim, 1993, 221-237.
35. Gmeiner, P., Bollinger, B., Tetrahedron Lett. 32 (1991), 5927-5930; Liebigs Ann. Chem. 1992, 273-278; Tetrahedron 50 (1994), 10909-10922.
36. Gmeiner, P., Bollinger, B., Tetrahedron Lett. 32 (1991), 5927-5930; Liebigs Ann. Chem. 1992, 273-278; Tetrahedron 50 (1994), 10909-10922.
37. Gmeiner, P., Bollinger, B., Tetrahedron Lett. 32 (1991), 5927-5930; Liebigs Ann. Chem. 1992, 273-278; Tetrahedron 50 (1994), 10909-10922.
38. Gull, P., Markstein, R., Swoboda, R., Eur. Pat. 0544240A1 (1992).
39. Dtsch. Apoth. Ztg. 133 (1993), 4850.
40. Drugs Fut. 7 (1982), 47-48; 8 (1983), 77; 9 (1984) 80; 11 (1986), 76; 15 (1990), 93; 16 (1991), 95-96.
41. Drugs Fut. 7 (1982), 47-48; 8 (1983), 77; 9 (1984) 80; 11 (1986), 76; 15 (1990), 93; 16 (1991), 95-96.
42. Drugs Fut. 7 (1982), 47-48; 8 (1983), 77; 9 (1984) 80; 11 (1986), 76; 15 (1990), 93; 16 (1991), 95-96.
43. Drugs Fut. 7 (1982), 47-48; 8 (1983), 77; 9 (1984) 80; 11 (1986), 76; 15 (1990), 93; 16 (1991), 95-96.
44. Drugs Fut. 7 (1982), 47-48; 8 (1983), 77; 9 (1984) 80; 11 (1986), 76; 15 (1990), 93; 16 (1991), 95-96.
45. Drugs Fut. 7 (1982), 47-48; 8 (1983), 77; 9 (1984) 80; 11 (1986), 76; 15 (1990), 93; 16 (1991), 95-96.
46. Jacobs, R. T., Ohnmacht, C. J., Trainor, D. A., Eur. Pat. 0532177A1 (1992); Klimas, M. T., Goldstein, J. M. u. a., Bioorg. Med. Chem. Lett. 5 (1995), 1795-1800.
47. Jacobs, R. T., Ohnmacht, C. J., Trainor, D. A., Eur. Pat. 0532177A1 (1992); Klimas, M. T., Goldstein, J. M. u. a., Bioorg. Med. Chem. Lett. 5 (1995), 1795-1800.
48. Chumpradit, S., Kung, P. M., Kung, H. F., J. Med. Chem. 36 (1993), 4308-4312; Chumpradit, S. u. a., ibid. 37 (1994), 4245-4250; Stange, Ph. G., Trends Pharmacol. Sci. 15 (1994) 317-319.
49. Chumpradit, S., Kung, P. M., Kung, H. F., J. Med. Chem. 36 (1993), 4308-4312; Chumpradit, S. u. a., ibid. 37 (1994), 4245-4250; Stange, Ph. G., Trends Pharmacol. Sci. 15 (1994) 317-319.
50. Chumpradit, S., Kung, P. M., Kung, H. F., J. Med. Chem. 36 (1993), 4308-4312; Chumpradit, S. u. a., ibid. 37 (1994), 4245-4250; Stange, Ph. G., Trends Pharmacol. Sci. 15 (1994) 317-319.
51. Hacksell, U. in Krogsgaard-Larsen, P., Bundgaard, H., A Textbook of Drug Design and Development, Harwood Academic Publishers Chur 1991, 42-54; Large, C. H., Stubbs, C. M., Trends Pharmacol. Sci. 15 (1994), 46-47; Sokoloff, P. u. a., Biochem. Pharmacol. 43 (1992), 659-666, Arzneim.-Forsch. 42 (1992), 224-230; Wikström, H. u. a., J. Med. Chem. 27 (1984), 1030-1036.
52. Hacksell, U. in Krogsgaard-Larsen, P., Bundgaard, H., A Textbook of Drug Design and Development, Harwood Academic Publishers Chur 1991, 42-54; Large, C. H., Stubbs, C. M., Trends Pharmacol. Sci. 15 (1994), 46-47; Sokoloff, P. u. a., Biochem. Pharmacol. 43 (1992), 659-666, Arzneim.-Forsch. 42 (1992), 224-230; Wikström, H. u. a., J. Med. Chem. 27 (1984), 1030-1036.
53. Hacksell, U. in Krogsgaard-Larsen, P., Bundgaard, H., A Textbook of Drug Design and Development, Harwood Academic Publishers Chur 1991, 42-54; Large, C. H., Stubbs, C. M., Trends Pharmacol. Sci. 15 (1994), 46-47; Sokoloff, P. u. a., Biochem. Pharmacol. 43 (1992), 659-666, Arzneim.-Forsch. 42 (1992), 224-230; Wikström, H. u. a., J. Med. Chem. 27 (1984), 1030-1036.
54. Hacksell, U. in Krogsgaard-Larsen, P., Bundgaard, H., A Textbook of Drug Design and Development, Harwood Academic Publishers Chur 1991, 42-54; Large, C. H., Stubbs, C. M., Trends Pharmacol. Sci. 15 (1994), 46-47; Sokoloff, P. u. a., Biochem. Pharmacol. 43 (1992), 659-666, Arzneim.-Forsch. 42 (1992), 224-230; Wikström, H. u. a., J. Med. Chem. 27 (1984), 1030-1036.
55. Hacksell, U. in Krogsgaard-Larsen, P., Bundgaard, H., A Textbook of Drug Design and Development, Harwood Academic Publishers Chur 1991, 42-54; Large, C. H., Stubbs, C. M., Trends Pharmacol. Sci. 15 (1994), 46-47; Sokoloff, P. u. a., Biochem. Pharmacol. 43 (1992), 659-666, Arzneim.-Forsch. 42 (1992), 224-230; Wikström, H. u. a., J. Med. Chem. 27 (1984), 1030-1036.
56. Wise, L. D., Jaen, J. C. in Kozikowski, A. P., Drug Design for Neuroscience, Raven Press New York 1993, 119-148; Drugs Fut. 19 (1994), 417; Wright, J. L. u.a., J. Med. Chem. 37 (1994), 3523-3533.
57. Wise, L. D., Jaen, J. C. in Kozikowski, A. P., Drug Design for Neuroscience, Raven Press New York 1993, 119-148; Drugs Fut. 19 (1994), 417; Wright, J. L. u.a., J. Med. Chem. 37 (1994), 3523-3533.
58. Wise, L. D., Jaen, J. C. in Kozikowski, A. P., Drug Design for Neuroscience, Raven Press New York 1993, 119-148; Drugs Fut. 19 (1994), 417; Wright, J. L. u.a., J. Med. Chem. 37 (1994), 3523-3533.
59. Barett, J. R., Drug News Perspect. 5 (1992), 453-460; Herndon, J. L., Glennon, R. A. in Kozikowski, A. P., Drug Design for Neuroscience, Raven Press New York 1993, 167-212; Waldmeier, P. C., Delini-Stula, A. A., Eur. J. Pharmacol. 55 (1979), 363-373.
60. Barett, J. R., Drug News Perspect. 5 (1992), 453-460; Herndon, J. L., Glennon, R. A. in Kozikowski, A. P., Drug Design for Neuroscience, Raven Press New York 1993, 167-212; Waldmeier, P. C., Delini-Stula, A. A., Eur. J. Pharmacol. 55 (1979), 363-373.
61. Barett, J. R., Drug News Perspect. 5 (1992), 453-460; Herndon, J. L., Glennon, R. A. in Kozikowski, A. P., Drug Design for Neuroscience, Raven Press New York 1993, 167-212; Waldmeier, P. C., Delini-Stula, A. A., Eur. J. Pharmacol. 55 (1979), 363-373.
62. Drugs Fut. 19 (1994), 114-117.
63. Fontenla, J. A. u. a., J. Med. Chem. 37 (1994), 2564-2573.
64. Neue Arzneimittel (Beilage Dtsch. Apoth. Ztg.) 41 (1994), 57-58; Henze, S., Dtsch. Apoth. Ztg. 134 (1994), 62; Drugs Fut. 13 (1988), 1052-1055.
65. Neue Arzneimittel (Beilage Dtsch. Apoth. Ztg.) 41 (1994), 57-58; Henze, S., Dtsch. Apoth. Ztg. 134 (1994), 62; Drugs Fut. 13 (1988), 1052-1055.
66. Neue Arzneimittel (Beilage Dtsch. Apoth. Ztg.) 41 (1994), 57-58; Henze, S., Dtsch. Apoth. Ztg. 134 (1994), 62; Drugs Fut. 13 (1988), 1052-1055.
67. Howard, H. R., Seeger, Th. F. in Bristol, J. A., Annu. Rep. Med. Chem. 28 (1993), 3947.
68. Drugs Fut. 19 (1994), 560-563; ibid. 16 (1991), 122-126.
69. Drugs Fut. 19 (1994), 560-563; ibid. 16 (1991), 122-126.
70. Peeregard, J. u. a., J. Med. Chem. 35 (1992), 1092-1101.
71. Drugs Fut. 17 (1992), 9-11.
72. Drugs Fut. 16 (1991), 437-442; Tulp, M. Th. M., Mol, F., J. Eur. Pharmacol. 183 (1990), 1109.
73. Drugs Fut. 16 (1991), 437-442; Tulp, M. Th. M., Mol, F., J. Eur. Pharmacol. 183 (1990), 1109.
74. Scott, M. K. u. a., J. Med. Chem. 35 (1992), 552-558.
75. Reitz, A. B. u. a., J. Med. Chem. 37 (1994), 1060-1062).
76. King, F. D., Sanger, G. J., Drugs Fut. 14 (1989), 875-889), 17 (1992) 71; Greenshaw, A. J., Trends Pharmacol. Sci. 14 (1993), 265-270; Robertson, D. W. u. a., J. Med. Chem. 35 (1992), 310-319; van Wijngaarden, I. u. a., ibid. 36 (1993), 3693-3696.
77. King, F. D., Sanger, G. J., Drugs Fut. 14 (1989), 875-889), 17 (1992) 71; Greenshaw, A. J., Trends Pharmacol. Sci. 14 (1993), 265-270; Robertson, D. W. u. a., J. Med. Chem. 35 (1992), 310-319; van Wijngaarden, I. u. a., ibid. 36 (1993), 3693-3696.
78. King, F. D., Sanger, G. J., Drugs Fut. 14 (1989), 875-889), 17 (1992) 71; Greenshaw, A. J., Trends Pharmacol. Sci. 14 (1993), 265-270; Robertson, D. W. u. a., J. Med. Chem. 35 (1992), 310-319; van Wijngaarden, I. u. a., ibid. 36 (1993), 3693-3696.
79. King, F. D., Sanger, G. J., Drugs Fut. 14 (1989), 875-889), 17 (1992) 71; Greenshaw, A. J., Trends Pharmacol. Sci. 14 (1993), 265-270; Robertson, D. W. u. a., J. Med. Chem. 35 (1992), 310-319; van Wijngaarden, I. u. a., ibid. 36 (1993), 3693-3696.
80. King, F. D., Sanger, G. J., Drugs Fut. 14 (1989), 875-889), 17 (1992) 71; Greenshaw, A. J., Trends Pharmacol. Sci. 14 (1993), 265-270; Robertson, D. W. u. a., J. Med. Chem. 35 (1992), 310-319; van Wijngaarden, I. u. a., ibid. 36 (1993), 3693-3696.
81. Zifa, E., Fillion, G., Pharmacol. Rev. 44 (1992), 401-458; Drugs Fut. 17 (1992), 987-990.
82. Zifa, E., Fillion, G., Pharmacol. Rev. 44 (1992), 401-458; Drugs Fut. 17 (1992), 987-990.